Total assets increased 272.1%
Total assets changed +272.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed +272.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +98.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -76.0% from the comparable as-filed period.
Operating cash flow changed -105.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +240.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed +254.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Trade receivables changed +171.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +85.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.